Os rotavírus são considerados a principal causa de gastrenterite grave em crianças abaixo de cinco anos, principalmente nos países em desenvolvimento. A vacinação nos primeiros meses de vida se constitui na medida mais ...

Objectives: Rotavirus vaccination was introduced in Brazil in March 2006, targeting an annual birth cohort of approximately 3.5 million. We analyzed trends in all-cause gastroenteritis-related deaths in children >5 years ...

Rotavirus vaccination was introduced in Brazil in March 2006.We describe trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years during pre- and postvaccination periods using hospital ...

Background: Brazil initiated universal immunization of infants with the G1P[8] human rotavirus (RV) vaccine in March 2006. This study evaluated vaccine effectiveness (VE) against severe rotavirus gastroenteritis (RVGE) ...

Concomitant serotypes 1 and 4 infections were detected in a 15-month old female child with community-acquired diarrhoea which lasted 7 days and coursed with moderate dehydration. The evidence for dual rotavirus infection ...

OBJETIVOS: Detectar a presença e definir os tipos de adenovírus humanos (HAdV) em indivíduos menores de 3 anos de idade, participantes de dois projetos de pesquisa sobre gastroenterites virais, realizados em Belém, ...

In 1984 an enzyme immunoassay for rotavirus and adenovirus developed in the Virology Department of the Oswaldo Cruz Foundation was distributed to laboratories in 14 Brazilian states as part of a proyect to survey viral ...

Background: Rotavirus (RV) vaccine, Rotarix, was introduced into the Brazil national immunization program in 2006. To estimate populationlevel vaccine effect, we conducted a time–trend analysis on all-cause gastroenter ...